Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Strategic Advocates LLC

Strategic Advocates LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,793 shares of the medical equipment provider's stock after selling 1,337 shares during the quarter. Intuitive Surgical comprises approximately 1.4% of Strategic Advocates LLC's portfolio, making the stock its 17th biggest position. Strategic Advocates LLC's holdings in Intuitive Surgical were worth $4,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of ISRG. Bennett Selby Investments LP increased its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. LVW Advisors LLC boosted its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Hazlett Burt & Watson Inc. raised its position in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock worth $177,000 after acquiring an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. lifted its position in Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after purchasing an additional 20 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the company's stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,843 shares of company stock worth $15,357,560. Insiders own 0.90% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on ISRG. Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $3.89 during mid-day trading on Friday, hitting $576.29. The stock had a trading volume of 811,493 shares, compared to its average volume of 1,952,707. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a 50 day moving average of $549.92 and a two-hundred day moving average of $508.00. The firm has a market cap of $205.26 billion, a PE ratio of 90.03, a PEG ratio of 5.52 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.